CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
Bioprospect Limited Company Snapshot
Business Description:
Bioprospect Limited operates in the Pharmaceutical preparations sector. BioProspect Limited is an Australia-based company. The Company conducts research and early stage commercialization in the pesticide and agricultural sectors. The Company operates in two segments: agriculture/animal health and human health/skin care. The agriculture/animal health segment includes the income and expenditure pertaining to Termilone, the Company's natural termiticide, Qcide, the Company's natural insecticide and the Bioeffectives range of plant extracts derived from coniferous trees. The human health/skin care segment includes the income and expenditure pertaining to the emu oil product range distributed through Re Gen Wellness Products Pty Ltd. Its subsidiaries include BioProspect Australia Limited Limited, Australian Phytochemicals Limited and BioProspect America Pty Ltd. On August 10, 2009, the Company acquired 10% of Re Gen Wellness Products Pty Ltd. In August 2011, the Company acquired additional 25% in Frontier Gasfields Pty Ltd. In our complete report available for purchase the company is compared to: RMG Limited, Smart Holdings Incorporation and Skybridge Technology Group, Inc..
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Bioprospect Limited
  Stock Performance Chart for Bioprospect Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): .00
(Figures in Australian Dollars)
1 Week -20.0%   13 Weeks n/a  
4 Weeks -33.3%   52 Weeks -69.2%  
 
Bioprospect Limited Key Data:
  Ticker: BPO Country: AUSTRALIA
  Exchanges: Major Industry: Miscellaneous
    Sub Industry: Service Organizations
  2011 Sales 294,042
(Year Ending Jan 2012).		 Employees: 4
  Currency: Australian Dollars Market Cap: 6,374,681
  Fiscal Yr Ends: June Shares Outstanding: 1,593,670,347
  Share Type: Ordinary Closely Held Shares: 256,872,199
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.